<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39355209</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2673-8880</ISSN><JournalIssue CitedMedium="Internet"><Volume>4</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in nuclear medicine (Lausanne, Switzerland)</Title><ISOAbbreviation>Front Nucl Med</ISOAbbreviation></Journal><ArticleTitle>QUALIPAED-A retrospective quality control study evaluating pediatric long axial field-of-view low-dose FDG-PET/CT.</ArticleTitle><Pagination><StartPage>1398773</StartPage><MedlinePgn>1398773</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1398773</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fnume.2024.1398773</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Pediatric patients have an increased risk of radiation-induced malignancies due to their ongoing development and long remaining life span. Thus, optimization of PET protocols is an important task in pediatric nuclear medicine. Long axial field-of-view (LAFOV) PET/CT has shown a significant increase in sensitivity, which provides an ideal opportunity for reduction of injected tracer activity in the pediatric population. In this study we aim to evaluate the clinical performance of a 2-[<sup>18</sup>F]FDG-tracer reduction from 3 MBq/kg to 1.5 MBq/kg on the Biograph Vision Quadra LAFOV PET/CT.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="UNASSIGNED">The first 50 pediatric patients referred for clinical whole-body PET/CT with 1.5 MBq/kg 2-[<sup>18</sup>F]FDG, were included. A standard pediatric protocol was applied. Five reconstructions were created with various time, filter and iteration settings. Image noise was computed as coefficient-of-variance (COV = SD/mean standardized-uptake-value) calculated from a spherical 20-50 mm (diameter) liver volume-of-interest. Sets of reconstructions were reviewed by one nuclear medicine physicians, who reported image lesions on a pre-defined list of sites. Paired comparison analysis was performed with significance at <i>P<sub>B</sub> &lt; 0.05</i> (Bonferroni corrected).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">All reconstructions, except one, achieved a COV<sub>mean</sub> (0.08-0.15) equal to or lower than current clinical acceptable values (COV<sub>ref</sub> ≤ 0.15). Image noise significantly improved with increasing acquisition time, lowering iterations (i) from 6i to 4i (both with five subsets) and when applying a 2 mm Gauss filter (<i>P<sub>B</sub> &lt; 0.001</i>). Significant difference in lesion detection was seen from 150s to 300s and from 150s to 600s (<i>P<sub>B</sub> = 0.006-0.007</i>). 99% of all lesions rated as malignant could be found on the 150s reconstruction, while 100% was found on the 300s, when compared to the 600s reconstruction.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Injected activity and scan time can be reduced to 1.5 MBq/kg 2-[<sup>18</sup>F]FDG with 5 min acquisition time on LAFOV PET/CT, while maintaining clinical performance in the pediatric population. These results can help limit radiation exposure to patients and personnel as well as shorten total scan time, which can help increase patient comfort, lessen the need for sedation and provide individually tailored scans.</AbstractText><CopyrightInformation>© 2024 Honoré d'Este, Andersen, Schulze, Saxtoft, Fischer and Andersen.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Honoré d'Este</LastName><ForeName>Sabrina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Flemming Littrup</ForeName><Initials>FL</Initials><AffiliationInfo><Affiliation>Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schulze</LastName><ForeName>Christina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saxtoft</LastName><ForeName>Eunice</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fischer</LastName><ForeName>Barbara Malene</ForeName><Initials>BM</Initials><AffiliationInfo><Affiliation>Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>King's College London &amp; Guy's and St Thomas' PET Centre, St Thomas' Hospital, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andersen</LastName><ForeName>Kim Francis</ForeName><Initials>KF</Initials><AffiliationInfo><Affiliation>Department of Clinical Physiology and Nuclear Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Nucl Med</MedlineTA><NlmUniqueID>9918470388806676</NlmUniqueID><ISSNLinking>2673-8880</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">LAFOV</Keyword><Keyword MajorTopicYN="N">Quadra</Keyword><Keyword MajorTopicYN="N">low-Dose 2-[18F]FDG</Keyword><Keyword MajorTopicYN="N">pediatric imaging</Keyword><Keyword MajorTopicYN="N">total-body PET/CT</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>4</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39355209</ArticleId><ArticleId IdType="pmc">PMC11440848</ArticleId><ArticleId IdType="doi">10.3389/fnume.2024.1398773</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ozasa K, Grant EJ, Kodama K. Japanese Legacy cohorts: the life span study atomic bomb survivor cohort and survivors’ offspring. J Epidemiol. (2018) 28(4):162–9. 10.2188/jea.JE20170321</Citation><ArticleIdList><ArticleId IdType="doi">10.2188/jea.JE20170321</ArticleId><ArticleId IdType="pmc">PMC5865006</ArticleId><ArticleId IdType="pubmed">29553058</ArticleId></ArticleIdList></Reference><Reference><Citation>Sgouros G, Frey EC, Bolch WE, Wayson MB, Abadia AF, Treves ST. An approach for balancing diagnostic image quality with cancer risk: application to pediatric diagnostic imaging of 99mTc- dimercaptosuccinic acid. J Nucl Med. (2011) 52(12):1923–9. 10.2967/jnumed.111.092221</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.111.092221</ArticleId><ArticleId IdType="pmc">PMC3290866</ArticleId><ArticleId IdType="pubmed">22144506</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahey FH, Treves ST, Adelstein SJ. Minimizing and communicating radiation risk in pediatric nuclear medicine. J Nucl Med. (2011) 52(8):1240–51. 10.2967/jnumed.109.069609</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.109.069609</ArticleId><ArticleId IdType="pubmed">21764783</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahey FH, Bom HHS, Chiti A, Choi YY, Huang G, Lassmann M, et al. Standardization of administered activities in pediatric nuclear medicine: a report of the first nuclear medicine global initiative project, part 1—statement of the issue and a review of available resources. J Nucl Med. (2015) 56(4):646–51. 10.2967/jnumed.114.152249</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.114.152249</ArticleId><ArticleId IdType="pubmed">25766899</ArticleId></ArticleIdList></Reference><Reference><Citation>Poli GL, Torres L, Coca M, Veselinovic M, Lassmann M, Delis H, et al. Paediatric nuclear medicine practice: an international survey by the IAEA. Eur J Nucl Med Mol Imaging. (2020) 47(6):1552–63. 10.1007/s00259-019-04624-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-019-04624-w</ArticleId><ArticleId IdType="pmc">PMC7188705</ArticleId><ArticleId IdType="pubmed">31813051</ArticleId></ArticleIdList></Reference><Reference><Citation>Chawla SC, Federman N, Zhang D, Nagata K, Nuthakki S, McNitt-Gray M, et al. Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review. Pediatr Radiol. (2010) 40(5):681–6. 10.1007/s00247-009-1434-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00247-009-1434-z</ArticleId><ArticleId IdType="pmc">PMC2847163</ArticleId><ArticleId IdType="pubmed">19967534</ArticleId></ArticleIdList></Reference><Reference><Citation>Nievelstein RAJ, Van Ufford HMEQ, Kwee TC, Bierings MB, Ludwig I, Beek FJA, et al. Radiation exposure and mortality risk from CT and PET imaging of patients with malignant lymphoma. Eur Radiol. (2012) 22(9):1946–54. 10.1007/s00330-012-2447-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00330-012-2447-9</ArticleId><ArticleId IdType="pmc">PMC3411290</ArticleId><ArticleId IdType="pubmed">22538627</ArticleId></ArticleIdList></Reference><Reference><Citation>Alessio AM, Sammer M, Phillips GS, Manchanda V, Mohr BC, Parisi MT. Evaluation of optimal acquisition duration or injected activity for pediatric18F-FDG PET/CT. J Nucl Med. (2011) 52(7):1028–34. 10.2967/jnumed.110.086579</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.110.086579</ArticleId><ArticleId IdType="pubmed">21680684</ArticleId></ArticleIdList></Reference><Reference><Citation>Spycher B, Lupatsch J, Zwahlen M. Background ionizing radiation and the risk of childhood cancer: a census-based nationwide cohort study. Environ Health Perspect. (2015) 123(6):622–8. 10.1289/ehp.1408548</Citation><ArticleIdList><ArticleId IdType="doi">10.1289/ehp.1408548</ArticleId><ArticleId IdType="pmc">PMC4455589</ArticleId><ArticleId IdType="pubmed">25707026</ArticleId></ArticleIdList></Reference><Reference><Citation>(EANM) EA of NM. Dosage Card. European Association of Nuclear Medicine (2016). p. 1. Available online at:
https://www.eanm.org/initiatives/dosage-card/
(cited March 20, 2023).</Citation></Reference><Reference><Citation>Treves ST, Gelfand MJ, Fahey FH, Parisi MT. 2016 update of the north American consensus guidelines for pediatric administered radiopharmaceutical activities. J Nucl Med. (2016) 57(12):15N–8N. PMID: .</Citation><ArticleIdList><ArticleId IdType="pubmed">27909182</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rijsewijk ND, van Leer B, Ivashchenko O V, Schölvinck EH, van den Heuvel F, van Snick JH, et al. Ultra-low dose infection imaging of a newborn without sedation using long axial field-of-view PET/CT. Eur J Nucl Med Mol Imaging. (2023) 50(2):622–3. 10.1007/s00259-022-05979-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-05979-3</ArticleId><ArticleId IdType="pmc">PMC9816243</ArticleId><ArticleId IdType="pubmed">36166078</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan H, Sui X, Yin H, Yu H, Gu Y, Chen S, et al. Total-body PET/CT using half-dose FDG and compared with conventional PET/CT using full-dose FDG in lung cancer. Eur J Nucl Med Mol Imaging. (2021) 48(6):1966–75. 10.1007/s00259-020-05091-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05091-4</ArticleId><ArticleId IdType="pubmed">33244618</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan H, Cai D, Sui X, Qi C, Mao W, Zhang Y, et al. Investigating ultra-low-dose total-body [18F]-FDG PET/CT in colorectal cancer: initial experience. Eur J Nucl Med Mol Imaging. (2022) 49(3):1002–11. 10.1007/s00259-021-05537-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05537-3</ArticleId><ArticleId IdType="pubmed">34462790</ArticleId></ArticleIdList></Reference><Reference><Citation>Badawi RD, Shi H, Hu P, Chen S, Xu T, Price PM, et al. First human imaging studies with the explorer total-body PET scanner. J Nucl Med. (2019) 60(3):299–303. 10.2967/jnumed.119.226498</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.119.226498</ArticleId><ArticleId IdType="pmc">PMC6424228</ArticleId><ArticleId IdType="pubmed">30733314</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachpekidis C, Pan L, Kopp-Schneider A, Weru V, Hassel JC, Dimitrakopoulou-Strauss A. Application of the long axial field-of-view PET/CT with low-dose [18F]FDG in melanoma. Eur J Nucl Med Mol Imaging. (2023) 50(4):1158–67. 10.1007/s00259-022-06070-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-06070-7</ArticleId><ArticleId IdType="pmc">PMC9931831</ArticleId><ArticleId IdType="pubmed">36474125</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao YM, Li YH, Chen T, Zhang WG, Wang LH, Feng J, et al. Image quality and lesion detectability in low-dose pediatric 18F-FDG scans using total-body PET/CT. Eur J Nucl Med Mol Imaging. (2021) 48(11):3378–85. 10.1007/s00259-021-05304-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05304-4</ArticleId><ArticleId IdType="pubmed">33738519</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Hu P, Yu H, Tan H, Zhang Y, Yin H, et al. Ultra-low-activity total-body dynamic PET imaging allows equal performance to full-activity PET imaging for investigating kinetic metrics of 18F-FDG in healthy volunteers. Eur J Nucl Med Mol Imaging. (2021) 48(8):2373–83. 10.1007/s00259-020-05173-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-05173-3</ArticleId><ArticleId IdType="pubmed">33479842</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Liu L, Li Y, Li S, Li Z, Zhang W, et al. Evaluation of pediatric malignancies using total-body PET/CT with half-dose [18F]-FDG. Eur J Nucl Med Mol Imaging. (2022) 49(12):4145–55. 10.1007/s00259-022-05893-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-022-05893-8</ArticleId><ArticleId IdType="pubmed">35788704</ArticleId></ArticleIdList></Reference><Reference><Citation>Nardo L, Schmall JP, Werner TJ, Malogolowkin M, Badawi RD, Alavi A. Potential roles of total-body PET/Computed Tomography in pediatric imaging. PET Clin. (2020) 15(3):271–9. 10.1016/j.cpet.2020.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpet.2020.03.009</ArticleId><ArticleId IdType="pmc">PMC8650798</ArticleId><ArticleId IdType="pubmed">32498982</ArticleId></ArticleIdList></Reference><Reference><Citation>Honoré d’Este S, Andersen FL, Andersen JB, Jakobsen AL, Sanchez Saxtoft E, Schulze C, et al. Potential clinical impact of LAFOV PET/CT: a systematic evaluation of image quality and lesion detection. Diagnostics. (2023) 13(21):3295. 10.3390/diagnostics13213295</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13213295</ArticleId><ArticleId IdType="pmc">PMC10650426</ArticleId><ArticleId IdType="pubmed">37958190</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham MM, Wahl RL, Hoffman JM, Yap JT, Sunderland JJ, Boellaard R, et al. Summary of the UPICT protocol for 18F-FDG PET/CT imaging in oncology clinical trials. J Nucl Med. (2015) 56(6):955–61. 10.2967/jnumed.115.158402</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.115.158402</ArticleId><ArticleId IdType="pmc">PMC4587663</ArticleId><ArticleId IdType="pubmed">25883122</ArticleId></ArticleIdList></Reference><Reference><Citation>Boellaard R, Delgado-Bolton R, Oyen WJG, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: eANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. (2015) 42(2):328–54. 10.1007/s00259-014-2961-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-014-2961-x</ArticleId><ArticleId IdType="pmc">PMC4315529</ArticleId><ArticleId IdType="pubmed">25452219</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaalep A, Sera T, Rijnsdorp S, Yaqub M, Talsma A, Lodge MA, et al. Feasibility of state of the art PET/CT systems performance harmonisation. Eur J Nucl Med Mol Imaging. (2018) 45(8):1344–61. 10.1007/s00259-018-3977-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-018-3977-4</ArticleId><ArticleId IdType="pmc">PMC5993859</ArticleId><ArticleId IdType="pubmed">29500480</ArticleId></ArticleIdList></Reference><Reference><Citation>Boellaard R, Willemsen A, Arends B, Visser EP. EARL Procedure for assessing PET/CT system specific patient FDG activity preparations for quantitative FDG PET/CT studies. (2013). p. 1–3. Available online at: https://earl.eanm.org/wp-content/uploads/2023/05/EARL_Manual_4.2.pdf (Accessed June 9, 2024).</Citation></Reference><Reference><Citation>Alberts I, Hünermund JN, Prenosil G, Mingels C, Bohn KP, Viscione M, et al. Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the biograph vision quadra with the biograph vision PET/CT. Eur J Nucl Med Mol Imaging. (2021) 48(8):2395–404. 10.1007/s00259-021-05282-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05282-7</ArticleId><ArticleId IdType="pmc">PMC8241747</ArticleId><ArticleId IdType="pubmed">33797596</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichkendler M, Andersen FL, Borgwardt L, Nygaard U, Albrecht-Beste E, Andersen KF, et al. A long axial field of view enables PET/CT in toddler without sedation. J Nucl Med. (2022) 63(12):1962. 10.2967/jnumed.121.263626</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.263626</ArticleId><ArticleId IdType="pubmed">35710737</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YQ, Hu PC, Wu RZ, Gu YS, Chen SG, Yu HJ, et al. The image quality, lesion detectability, and acquisition time of 18F-FDG total-body PET/CT in oncological patients. Eur J Nucl Med Mol Imaging. (2020) 47(11):2507–15. 10.1007/s00259-020-04823-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-020-04823-w</ArticleId><ArticleId IdType="pubmed">32424483</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundhedsstyrelsen. Patientdosimetri ved CT-skanninger af voksne—indsamling og vurdering af patientdoser til sammenligning med referencedoser. Sundhedsstyrelsen. (2022) (1.0) 2022:1–28. ISBN: 978-87-7014-448-3</Citation></Reference><Reference><Citation>Bombardieri E, Aktolun C, Baum RP, Bishof-Delaloye A, Buscombe J, Chatal JF, et al. FDG-PET: procedure guidelines for tumour imaging. Eur J Nucl Med Mol Imaging. (2003) 30(12):BP115–24. 10.1007/s00259-003-1355-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-003-1355-2</ArticleId><ArticleId IdType="pubmed">14989224</ArticleId></ArticleIdList></Reference><Reference><Citation>European Commission, Directorate-General for Energy. European guidelines on diagnostic reference levels for paediatric imaging. Publications Office (2018). 10.2833/486256</Citation><ArticleIdList><ArticleId IdType="doi">10.2833/486256</ArticleId></ArticleIdList></Reference><Reference><Citation>Camoni L, Santos A, Luporsi M, Grilo A, Pietrzak A, Gear J, et al. EANM procedural recommendations for managing the paediatric patient in diagnostic nuclear medicine. Eur J Nucl Med Mol Imaging. (2023) 50(13):3862–79. 10.1007/s00259-023-06357-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-023-06357-3</ArticleId><ArticleId IdType="pmc">PMC10611649</ArticleId><ArticleId IdType="pubmed">37555902</ArticleId></ArticleIdList></Reference><Reference><Citation>ICRP. Radiation Dose to Patients from Radiopharmaceuticals: A Compendium of Current Information Related to Frequently Used Substances. Vol Ann ICRP, ICRP Publication 128 (2015). Available online at:
www.icrp.org</Citation></Reference><Reference><Citation>Aydos U, Balci E, Gülbahar Ateş S, Akdemir ÜÖ, Karadeniz C, Atay LÖ. Quantitative and visual analyses of the effect of activity reduction on image metrics and quality in 18F-FDG PET/MRI in pediatric oncology. Turkish J Med Sci. (2023) 53(1):289–302. 10.55730/1300-0144.5584</Citation><ArticleIdList><ArticleId IdType="doi">10.55730/1300-0144.5584</ArticleId><ArticleId IdType="pmc">PMC10387842</ArticleId><ArticleId IdType="pubmed">36945939</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery ME, Andersen FL, d’Este SH, Overbeck N, Cramon PK, Law I, et al. Attenuation correction of long axial field-of-view positron emission tomography using synthetic computed tomography derived from the emission data: application to low-count studies and multiple tracers. Diagnostics. (2023) 13(24):3661. 10.3390/diagnostics13243661</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13243661</ArticleId><ArticleId IdType="pmc">PMC10742516</ArticleId><ArticleId IdType="pubmed">38132245</ArticleId></ArticleIdList></Reference><Reference><Citation>Padma S, Sundaram PS, Tewari A. PET/CT in paediatric malignancies—an update. Indian J Med Paediatr Oncol. (2016) 37(3):131–40. 10.4103/0971-5851.190358</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0971-5851.190358</ArticleId><ArticleId IdType="pmc">PMC5027784</ArticleId><ArticleId IdType="pubmed">27688605</ArticleId></ArticleIdList></Reference><Reference><Citation>Vali R, Alessio A, Balza R, Borgwardt L, Bar-Sever Z, Czachowski M, et al. SNMMI procedure standard/EANM practice guideline on pediatric 18F-FDG PET/CT for oncology 1.0. J Nucl Med. (2021) 62(1):99–110. 10.2967/jnumed.120.254110</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.120.254110</ArticleId><ArticleId IdType="pmc">PMC8679588</ArticleId><ArticleId IdType="pubmed">33334912</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong TS, Shammas A, Charron M, Zukotynski KA, Drubach LA, Lim R. Brown adipose tissue 18F-FDG uptake in pediatric PET/CT imaging. Pediatr Radiol. (2011) 41(6):759–68. 10.1007/s00247-010-1925-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00247-010-1925-y</ArticleId><ArticleId IdType="pubmed">21161205</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant FD. Normal variations and benign findings in pediatric 18F-FDG-PET/ CT. PET Clin. (2014) 9(2):195–208. 10.1016/j.cpet.2013.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpet.2013.12.002</ArticleId><ArticleId IdType="pubmed">25030282</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal A, Shah S, Gnanasegaran G, Rajkotia S, Purandare N, Puranik A, et al. PET/CT normal variants and pitfalls in pediatric disorders. Semin Nucl Med. (2021) 51(6):572–83. 10.1053/j.semnuclmed.2021.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.semnuclmed.2021.06.007</ArticleId><ArticleId IdType="pubmed">34243902</ArticleId></ArticleIdList></Reference><Reference><Citation>Prenosil GA, Sari H, Fürstner M, Afshar-Oromieh A, Shi K, Rominger A, et al. Performance characteristics of the biograph vision quadra PET/CT system with long axial field of view using the NEMA NU 2-2018 standard. J Nucl Med. (2022) 63(3):476–84. 10.2967/jnumed.121.261972</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.121.261972</ArticleId><ArticleId IdType="pubmed">34301780</ArticleId></ArticleIdList></Reference><Reference><Citation>Spencer BA, Berg E, Schmall JP, Omidvari N, Leung EK, Abdelhafez YG, et al. Performance evaluation of the uEXPLORER total-body PET/CT scanner based on NEMA NU 2-2018 with additional tests to characterize PET scanners with a long axial field of view. J Nucl Med. (2021) 62(6):861–70. 10.2967/jnumed.120.250597</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.120.250597</ArticleId><ArticleId IdType="pmc">PMC8729871</ArticleId><ArticleId IdType="pubmed">33008932</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>